Denali Therapeutics (4DN) Revenue

7 Followers

Denali Therapeutics Revenue

Denali Therapeutics had a revenue of 3.60M in the quarter ending Jun 30, 2026, with Infinity%. This bring the company's revenue in the last twelve months to 3.60M, Decreased Infinity%. In the fiscal year ending Dec 31, 2025, Denali Therapeutics had annual revenue of 0.00 with ― growth.

Revenue (ttm)

3.60M

Revenue Growth

―

P/S Ratio

―

Revenue/Employee

€0

Employees

503

Market Cap

€3.14B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	―	―	―
Dec 31, 2024	―	-330.53M	-100.00%
Dec 31, 2023	330.53M	222.07M	+204.74%
Dec 31, 2022	108.46M	59.80M	+122.90%
Dec 31, 2021	48.66M	-287.00M	-85.50%
Dec 31, 2020	335.66M	308.98M	+1,158.19%
Dec 31, 2019	26.68M	-102.48M	-79.34%
Dec 31, 2018	129.16M	―	+∞%
Dec 31, 2017	―	―	―